Verwendung: Dieses Produkt ist ausschließlich für Forschungszwecke bestimmt.
Alle Produktinformationen auf dieser Website dienen ausschließlich Bildungszwecken. Jede Form der Einbringung in den Körper von Menschen oder Tieren ist gesetzlich streng verboten. Dieses Produkt darf nur von zugelassenen und qualifizierten Fachleuten gehandhabt werden. Es ist kein Arzneimittel, Lebensmittel oder Kosmetikum und darf nicht als solches gekennzeichnet, verwendet oder falsch etikettiert werden.
9-Me-BC (9mbc), (15mg/capsule) 60 Capsules
Während der Umstellung unserer Verpackung erhalten Sie möglicherweise Produkte mit dem bisherigen oder dem neuen Etikett. Formulierung, Reinheit und Qualität bleiben nach unseren Standards genau gleich.
- Kreditkarte
- Banküberweisung (SEPA Echtzeit)
- Banküberweisung (ACH)
- Wise
- Revolut
- Zelle
- Remitly
- Western Union
- Chime
- Andere
-25% auf alles – bis 31. Oktober
25% auf reguläre Preise statt anderer Angebote. Nur mit dem Krypto-Zahlungsrabatt kombinierbar.
Jede Charge wird auf Reinheit, Wirksamkeit und Qualität geprüft.
Laborergebnisse ansehen →9-Me-BC (9-Methyl-β-carboline) is a synthetic compound demonstrating monoamine oxidase interaction properties in experimental models. Laboratory research indicates specific modulation of amine-related molecular pathways.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
3D Molecular Structure
Drag to rotate · scroll to zoom| Chemical Formula | C12H10N2 |
|---|---|
| Synonyms | 9-Methyl-beta-carboline, 9-Methyl-norharman, 9-methylpyrido[3,4-b]indole |
| Molar Mass | 182.22 g/mol |
| CAS Number | 2521-07-5 |
| PubChem CID | 164979 |
| Total Compound Content | 900 mg (15 mg per capsule) |
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
How does 9-Me-BC's mechanism differ from classical MAO inhibitors used in research?
9-Me-BC is a β-carboline-derived compound with selective MAO-A inhibitory activity and a broader molecular interaction profile than many classical MAO inhibitors. Experimental investigations have examined its effects on monoamine-associated signaling pathways, transcriptional regulation mechanisms, and intracellular regulatory networks.
This combination of MAO-A inhibition and pathway-modulating activity makes it a useful research tool for studies investigating molecular signaling processes beyond monoamine oxidase inhibition alone.
What regulatory pathways have been investigated in studies of 9-Me-BC?
Experimental studies have examined 9-Me-BC in relation to neurotrophin-associated regulatory networks, gene expression mechanisms, and intracellular signaling pathways. Investigations have explored its interactions with transcriptional control systems, molecular communication pathways, and regulatory processes involved in cellular signaling.
These characteristics have contributed to its use in studies of molecular regulation, signal transduction, and β-carboline pharmacology.
Why is 9-Me-BC useful as a research tool in monoamine pharmacology?
9-Me-BC combines selective MAO-A inhibitory activity with documented interactions across multiple signaling and regulatory pathways. This profile makes it useful for investigating monoamine-associated mechanisms, transcriptional regulation, intracellular signaling processes, and structure-function relationships within the β-carboline class.
Its well-characterized molecular pharmacology has established it as a valuable tool for mechanistic studies of regulatory pathway interactions and monoamine-related signaling systems.
